Will Musk Back Out Of The Twitter Deal? | Ep. 1494

FDA Issues

The baby formula shortage in the U.S. has highlighted significant issues with the FDA's response to safety concerns. A whistleblower alerted the FDA about potential problems at a Michigan factory back in October, but the agency delayed action until January, leading to a recall in February. Ben Shapiro criticizes the administration's handling of the situation, noting the severe impact on families who rely on formula 1.

The FDA had a whistleblower back in October who said that they thought that there might be a problem at the Michigan factory. The FDA did nothing.

--- Ben Shapiro

This delay in response has exacerbated the shortage, with Abbott Laboratories struggling to meet demand despite efforts to import products from Ireland 2.

   

Government Response

The government's role in addressing the baby formula shortage has been questioned, with Ben Shapiro arguing that the administration lacks a clear plan. Despite claims that resolving the shortage is a top priority, Shapiro suggests that the White House's efforts are insufficient and reactive 3.

When it comes to this being a top priority for Biden, basically all that means is that he gets on the phone and jabbers with somebody, but he has no plan for any of this.

--- Ben Shapiro

The administration's conversations with major retailers and formula manufacturers have yet to yield significant progress, leaving many families in a precarious situation 2.